How Long Does Tramadol Stay in Your System?

Tramadol is typically detectable for 1–4 days in urine, about 1–2 days in blood, about 1–2 days in saliva, and for weeks to months in hair, depending on the dose, formulation, metabolism, and test type used (ARUP Consult, 2025; DailyMed, 2025).

Urine testing is often the main focus because urine tests are commonly used to check recent drug use, and tramadol leaves the body largely through urine. ARUP Consult lists tramadol and O-desmethyltramadol, its active metabolite, with a typical 1–4 day urine detection window after the last dose (ARUP Consult, 2025).

After an oral dose, tramadol peaks in the blood in about 2 hours, while O-desmethyltramadol peaks in about 3 hours. The average half-life is about 6.3 hours for tramadol and 7.4 hours for O-desmethyltramadol, but detection can last longer than the noticeable effects of the medication (DailyMed, 2025).

Key Takeaways

• Tramadol is commonly detectable in urine for 1–4 days after the last dose. This applies to tramadol itself and M1, its active metabolite (ARUP Consult, 2025).
• A single 50 mg immediate-release dose may stop feeling active within several hours, but urine testing may still detect tramadol or its metabolites for 1–4 days (ARUP Consult, 2025; DailyMed, 2025).
• Blood levels peak at about 2 hours, while M1 peaks at about 3 hours after oral use (DailyMed, 2025).
• The mean terminal half-life is about 6.3 hours for tramadol and 7.4 hours for M1, but detection can last longer than the drug’s noticeable effects (DailyMed, 2025).
• Some basic opioid panels may not detect tramadol by name. A specialized test or expanded opioid panel may be needed (ARUP Laboratories, n.d.).
• A urine test may look for tramadol and M1. Mayo Clinic Laboratories states that either substance at 25 ng/mL or higher is a strong indicator of use (Mayo Clinic Laboratories, n.d.).
• Extended-release use, repeated dosing, kidney impairment, and severe liver impairment may extend the timeline. DailyMed reports severe liver impairment can increase half-lives to 13 hours for tramadol and 19 hours for M1 (DailyMed, 2025).
• CYP2D6 differences can change how the medication is converted into M1. Pharmacokinetic studies show genotype can affect tramadol and metabolite exposure (Haage et al., 2018; Lee et al., 2019).
• Stopping suddenly after regular use can cause withdrawal. DailyMed recommends gradual tapering for people who are physically dependent on opioids (DailyMed, 2025).

Tramadol Detection Times by Test Type

Test Type	Typical Detection Window	What It Usually Shows
Urine	1–4 days	Recent use over several days
Blood	Usually recent use	Current or recent exposure
Saliva	Short-term exposure	Recent use; timing depends on the assay
Hair	Variable; often longer-term	Broader exposure pattern

Detection windows are estimates. Results can vary based on dose, timing, and test cutoff. ARUP notes that detection limits vary by assay, so the testing lab should be consulted about specific methods (ARUP Consult, 2025).

Urine testing is usually the main concern because tramadol is eliminated through urine with its metabolites. ARUP lists the urine detection window for tramadol and M1 at 1–4 days (ARUP Consult, 2025).

Quick Answers About Tramadol Stay

Urine Test Window

The medication is commonly detectable in urine for 1–4 days after the last dose. This window may be longer with repeated use, higher doses, or slower elimination.

A tramadol-specific urine test may look for both tramadol and M1. Mayo Clinic Laboratories notes that either substance at 25 ng/mL or higher is a strong indicator of use (Mayo Clinic Laboratories, n.d.).

50 mg or One Tablet Timing

A single 50 mg tramadol dose may be detectable in urine for 1–4 days. Tramadol itself may clear sooner, but urine testing can still detect metabolites after the effects wear off (ARUP Consult, 2025).

DailyMed reports that immediate-release tramadol has been studied in single oral doses of 50 mg, 75 mg, and 100 mg. The mean terminal half-life is about 6.3 hours for tramadol and 7.4 hours for M1, its active metabolite (DailyMed, 2025).

One immediate-release tablet is commonly 50 mg, though strengths and formulations can vary. Pain relief may fade within several hours, but detection can last longer because the body removes metabolites through urine.

Standard Drug Tests and Panels

Tramadol may not appear on every standard panel. Many basic opioid screens focus on substances such as morphine or codeine. A tramadol-specific drug test or expanded opioid panel may be needed.

ARUP lists a urine screen with reflex to quantitation for compliance or abuse screening. It also lists quantitative testing for tramadol and M1 (ARUP Laboratories, n.d.; ARUP Laboratories, n.d.).

If you have a valid prescription, follow the testing program’s process for reporting medication. If a result is unexpected, ask whether confirmatory testing is available.

Duration of Effects

Tramadol’s effects do not last as long as its full detection window. Immediate-release products are commonly prescribed every 4–6 hours as needed for pain. Extended-release products are designed for longer pain control (DailyMed, 2025; DailyMed, 2025).

Pain relief or sedation may fade while the medication remains detectable. This difference matters for drug tests because a person may feel normal before the drug has fully cleared.

The effects may last longer in people with kidney or liver impairment. DailyMed reports that severe liver impairment can increase half-lives to 13 hours for tramadol and 19 hours for M1. Renal impairment can also reduce excretion of both compounds (DailyMed, 2025).

Immediate-Release vs. Extended-Release Forms

Immediate-release tramadol enters the bloodstream faster and is used for shorter-term pain. DailyMed lists immediate-release dosing at 50 mg to 100 mg every 4–6 hours as needed, with a maximum daily dose of 400 mg for many adults (DailyMed, 2025).

Extended-release tramadol releases medication more slowly. This form is meant for longer pain control, not as-needed pain spikes. DailyMed describes extended-release products as a 24-hour dosing regimen and warns not to exceed dose limits (DailyMed, 2025).

Extended-release products may lengthen exposure because the medication enters the body over a longer period. A person using extended-release medication daily may have a longer detection window than someone who took one immediate-release dose.

Tramadol Half-Life and Clearance Timeline

A drug’s half-life is the time it takes the body to reduce the amount of medication in the blood by half.

The mean terminal half-life is about 6.3 hours for tramadol and about 7.4 hours for M1. With multiple dosing, the plasma elimination half-life increases from about 6 hours to about 7 hours (DailyMed, 2025).

Many medications take about five half-lives to mostly clear. Based on the average half-life, much of tramadol itself may clear within 1–2 days. Urine testing can still detect metabolites longer, with ARUP listing a 1–4 day urine window (ARUP Consult, 2025).

How the Body Metabolizes It

The medication is processed mainly by the liver. It is metabolized through several pathways, including CYP2D6 and CYP3A4. CYP2D6 helps form M1, an active metabolite (DailyMed, 2025).

DailyMed reports that about 30% of a dose is excreted in urine as unchanged tramadol. About 60% is excreted as metabolites. The kidneys then help eliminate these substances from the body (DailyMed, 2025).

This matters because liver function, kidney function, and certain medications can change processing. CYP2D6 inhibitors such as fluoxetine, paroxetine, and quinidine may affect metabolism (DailyMed, 2025). A pharmacokinetic study also found that CYP2D6, CYP2B6, and CYP3A4 genotype can affect exposure to tramadol and its metabolites (Haage et al., 2018).

Why Tramadol Stays Detectable Longer for Some People

Several factors can affect how long tramadol stays detectable:

• Dose: Higher doses may take longer to clear.
• Frequency: Repeated use can extend detection.
• Formulation: Extended-release products may lengthen exposure.
• Kidney function: Impairment can slow elimination.
• Liver function: Severe impairment can increase half-lives.
• Age: Adults over 75 may have a longer half-life.
• Test method: Different assays use different cutoffs.

DailyMed reports that severe hepatic impairment can increase half-lives to 13 hours for tramadol and 19 hours for M1. It also notes that impaired kidney function decreases the rate and extent of excretion (DailyMed, 2025).

Pharmacokinetic research in older patients also supports that patient-specific factors can influence tramadol and M1 exposure. This is one reason exact detection timing can vary from person to person (Al-Qurain et al., 2022).

False Positives and Confirmatory Testing

False positives can happen with some drug screens, but screening tests are not always definitive. A more specific test may be needed when results do not match the person’s medication history.

A 2023 case report described false-positive tramadol urine screens in two patients taking fexofenadine. The authors noted that immunoassays can produce false-positive results and that confirmatory testing is important for unexpected results (Yousuf et al., 2023).

If you take tramadol by prescription, report it according to the testing program’s instructions. If the result is unclear, ask whether confirmatory testing is available.

Can You Clear It Faster?

The body clears tramadol through normal metabolism and urine excretion. The timeline depends on the dose, test cutoff, and individual health factors (DailyMed, 2025; ARUP Consult, 2025).

Detox drinks, excessive water intake, and test-altering methods do not reliably change the biological detection window. These methods may also create confusing or invalid results.

Do not stop or change prescribed medication without medical guidance. Stopping suddenly after regular use may cause withdrawal symptoms (DailyMed, 2025).

Side Effects and Safety Risks When Taking It

Tramadol can cause side effects even when taking it as prescribed. Common side effects may include dizziness, drowsiness, and constipation. Some people may also experience nausea or sweating (DailyMed, 2025).

More serious risks include slowed breathing, seizures, and serotonin syndrome. These risks can increase when tramadol is combined with alcohol or sedatives (DailyMed, 2025).

MedlinePlus warns that tramadol can cause serious or life-threatening breathing problems, especially during the first 24–72 hours of treatment or after a dose increase. It also warns against drinking alcohol during treatment because alcohol can increase serious side effects (MedlinePlus, 2024).

Withdrawal Timeline

Tramadol withdrawal can happen after regular use, especially when the dose is stopped suddenly or reduced too quickly. Symptoms vary based on dose, duration of use, and health factors.

Early symptoms may include anxiety, sweating, and trouble sleeping. More intense symptoms may include nausea, diarrhea, and body aches. Some people may also experience mood changes or cravings.

DailyMed warns not to abruptly discontinue tramadol in a physically dependent patient. It recommends gradual tapering and notes that rapid discontinuation can lead to serious withdrawal (DailyMed, 2025).

Misuse and Addiction Risk

Tramadol can be habit-forming, especially with prolonged use. MedlinePlus advises taking tramadol exactly as directed and not taking more than prescribed (MedlinePlus, 2024).

Misuse can include higher doses, someone else’s prescription, or nonmedical use. The risk can rise when the medication is mixed with alcohol, other opioids, or sedatives.

Addiction can develop when use becomes hard to control. It may involve cravings, continued use despite harm, or repeated attempts to cut back. Addiction treatment can help address the behavior, withdrawal risk, and mental health concerns that often keep a person stuck.

Long-term misuse may also overlap with substance abuse involving alcohol or other drugs. In those cases, addiction treatment may need to address more than one substance at the same time.

Signs of Misuse

Misuse can be difficult to recognize because use may begin with a valid prescription. Warning signs may include higher-than-prescribed use, early refills, or using the medication for reasons other than pain.

Physical signs may include heavy sedation, confusion, or slowed breathing. Behavioral signs may include cravings, doctor shopping, or continued use despite problems at work or home.

Physical dependence and addiction are not the same. Dependence means the body has adapted to the medication. Addiction involves loss of control, cravings, and continued use despite harm.

Personalized Addiction Care in Washington

If you or a loved one use tramadol and find it difficult to stop, you may have developed a tramadol addiction. The Recovery Village Ridgefield has a strong record of helping those with tramadol addiction and can provide knowledgeable, compassionate care. Reach out to a Recovery Advocate to learn how to start on your recovery path today.

Treatment can help people manage detox symptoms, address opioid addiction, and build a recovery plan. Medical detox may be recommended when withdrawal risk is high. Inpatient rehab can provide structure and support, while outpatient treatment may help people continue care as they return to daily life.

A full treatment plan may include mental health therapy, relapse prevention, and recovery support. Addiction treatment can also help people address alcohol use, other drugs, or co-occurring mental health concerns when they are part of the problem.

If tramadol use is affecting your health, safety, or relationships, help is available. A confidential conversation with a Recovery Advocate can help you understand treatment options, including detox, rehab, outpatient care, and ongoing recovery support.

Frequently Asked Questions

What is the usual urine window?

Tramadol is commonly detectable in urine for 1–4 days after the last dose. Blood and saliva usually show more recent use. Hair testing may show a longer exposure pattern (ARUP Consult, 2025).

What about a 50 mg dose?

A single 50 mg dose may be detectable in urine for 1–4 days. Tramadol itself may mostly clear sooner, but urine testing may still detect metabolites after the effects fade (ARUP Consult, 2025; DailyMed, 2025).

Does one tablet clear faster?

One immediate-release tablet may be detectable in urine for 1–4 days. The timeline can be longer with repeated use, higher doses, or slower elimination (ARUP Consult, 2025).

Will standard panels catch it?

Tramadol may not appear on every standard panel. A tramadol-specific test or expanded opioid panel may be needed (ARUP Laboratories, n.d.).

How long do the effects last?

Immediate-release tramadol is commonly dosed every 4–6 hours as needed for pain. Extended-release tramadol is designed for longer, around-the-clock pain control (DailyMed, 2025).

Can you flush it out faster?

Detox drinks and excessive water intake do not reliably clear tramadol faster. The body needs time to metabolize and eliminate it.

Is sudden stopping safe?

Stopping suddenly after regular use can cause withdrawal. DailyMed warns not to abruptly discontinue tramadol in physically dependent patients and recommends gradual tapering (DailyMed, 2025).

When should someone seek help?

Seek help if use feels hard to control, causes withdrawal, or continues despite harm. Call 911 if someone has severe sleepiness, slowed breathing, or becomes unresponsive.

References

Al-Qurain, A. A., Upton, R. N., Tadros, R., Roberts, M. S., & Wiese, M. D. (2022). Population pharmacokinetic model for tramadol and O-desmethyltramadol in older patients. European Journal of Drug Metabolism and Pharmacokinetics, 47(3), 387–402. Full hyperlink: https://pmc.ncbi.nlm.nih.gov/articles/PMC9050769/

ARUP Consult. (2025). Drug half-lives and urine detection windows. ARUP Laboratories. Full hyperlink: https://arupconsult.com/content/drug-half-lives-and-urine-detection-windows

ARUP Laboratories. (n.d.). Tramadol, urine screen with reflex to quantitation. Full hyperlink: https://ltd.aruplab.com/Tests/Pub/2012297

ARUP Laboratories. (n.d.). Tramadol and metabolite, urine, quantitative. Full hyperlink: https://ltd.aruplab.com/Tests/Pub/2002736

DailyMed. (2025). Tramadol hydrochloride tablet: Prescribing information. U.S. National Library of Medicine. Full hyperlink: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1d4af58f-17f3-4cbd-870c-098ace954872

DailyMed. (2025). Tramadol hydrochloride extended-release tablet: Prescribing information. U.S. National Library of Medicine. Full hyperlink: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5285f056-c32c-4e7a-bec6-3a726aa23d5a

Haage, P., Kronstrand, R., Josefsson, M., & Calistri, S. (2018). Enantioselective pharmacokinetics of tramadol and its three main metabolites: Impact of CYP2D6, CYP2B6, and CYP3A4 genotype. Pharmacology Research & Perspectives, 6(4), e00419. Full hyperlink: https://pubmed.ncbi.nlm.nih.gov/29992026/

Lee, J., Yoo, H.-D., Bae, J.-W., Lee, S., & Shin, K.-H. (2019). Population pharmacokinetic analysis of tramadol and O-desmethyltramadol with genetic polymorphism of CYP2D6. Drug Design, Development and Therapy, 13, 1751–1761. Full hyperlink: https://pmc.ncbi.nlm.nih.gov/articles/PMC6537040/

Mayo Clinic Laboratories. (n.d.). Tramadol and metabolite, random, urine. Full hyperlink: https://www.mayocliniclabs.com/test-catalog/overview/62595

MedlinePlus. (2024). Tramadol. U.S. National Library of Medicine. Full hyperlink: https://medlineplus.gov/druginfo/meds/a695011.html

Yousuf, S. M., Yassin, A., Alzghari, S. K., & Rickner, S. S. (2023). False positive tramadol urine testing in patients taking fexofenadine: A tale of two consecutive cases. Case Reports in Psychiatry. Full hyperlink: https://pmc.ncbi.nlm.nih.gov/articles/PMC9836806/